Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was discarded.A review of the device history record has been completed.No deviations or non-conformances noted.This is a known potential adverse event addressed in the product labeling.
|
Healthcare professional (hcp) reported that patient was injected with 2ml juvéderm® voluma¿ with lidocaine and 2ml juvéderm® volift¿ with lidocaine in cheeks and lips.Approximately two and a half months later, after an episode of cold sores, patient developed edema and erythema similar to "granuloma-like reaction." biopsy was not provided.Patient was treated with predsim 40 mg for 15 days, clavulin bd for 7 days, and valtrex for 10 days.Patient was also treated with 3000 iu of hyaluronidase (biometil) into the nodules.Symptoms are evolving with partial improvement, but with persistence of nodules.This is the same event and the same patient reported under mdr id# 3005113652-2021-03195 (allergan complaint #(b)(4)).This mdr is being submitted for the suspect product, juvéderm® voluma¿ with lidocaine.
|